Abdolkarim Sheikhi
6PUBLICATIONS
18CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Feb 26, 2025
Novel sACE2-Anti-CD16VHH Fusion Protein Surreptitiously Inhibits SARS-CoV-2 Variant Spike Proteins and Macrophage Cytokines, and Activates Natural Killer Cell Cytotoxicity.Abdolkarim Sheikhi, Leili Baghaie, Fatemeh Rahbarizadeh
|Oct 28, 2024
Anti-PD-L1 chimeric antigen receptor natural killer cell: Characterization and functional analysis.Mahsa Yazdanpanah-Samani, Amin Ramezani, Abdolkarim Sheikhi
|Oct 28, 2023
Contemporaneous SARS-CoV-2-Neutralizing Antibodies Mediated by N-glycan Shields.Leili Baghaie, Fleur Leroy, Mehdi Sheikhi
|Sep 11, 2023
The correlation between humoral immune responses and severity of clinical symptoms in COVID-19 patients.Shadi Akbarian, Mehdi Sheikhi, Parichehr Khedri
|Nov 13, 2021
Enhancement of NK Cell Antitumor Effector Functions Using a Bispecific Single Domain Antibody Targeting CD16 and the Epidermal Growth Factor Receptor.Elisa C Toffoli, Abdolkarim Sheikhi, Roeland Lameris
|Jul 15, 2020
An immunotherapeutic method for COVID-19 patients: a soluble ACE2-Anti-CD16 VHH to block SARS-CoV-2 Spike protein.Abdolkarim Sheikhi, Mohammad Hojjat-Farsangi
Pageof 1
Frequent Collaborators
2 joint publications
Leili Baghaie
2 joint publications
Myron R Szewczuk
1 joint publications
Mohammad Hojjat-Farsangi
1 joint publications
Elisa C Toffoli
1 joint publications
Amanda van Vliet
1 joint publications
Bruce Walcheck
1 joint publications
Henk M W Verheul
1 joint publications
Jurriaan Tuynman
1 joint publications
Fleur Leroy
1 joint publications
Mahsa Yazdanpanah-Samani
